A European Centre of Excellence for baromedical research, education and treatment. +44 (0) 1752 209999 [email protected] Osteoradionecrosis http://www.ddrc.org Osteoradionecrosis and hyperbaric oxygen: Osteoradionecrosis (ORN) is a complication of radiation exposure, occurring when irradicated bone becomes devitalised. The presentation of ORN ranges from necrotic soft tissue damage, to bone erosion, to pathological fractures. Contributing factors to the development of ORN are well known. Radiation dosage, delivery and fractionation and elapsed time since radiation and its contribution to ORN have been studied by Marx (1984), Beumer et al. (1984), Maxymiw et al. (1991) and Curi et al. (1997). Oral hygiene, alcohol and tobacco use, and concomitant chemotherapy also play a role. Hyperbaric oxygen (HBO) increases the blood-tissue oxygen gradient which enhances the diffusion of oxygen into hypoxic tissues. The increased oxygen supply stimulates fibroblast proliferation, angiogenesis, and collagen formation. Additionally the increased oxygen is bactericidal and bacteriostatic. prophylactic hyperbaric oxygen is effective in reducing the risk of developing ORN after post-radiation extractions. In a review and rationale for treatment planning Schoen et al (2003) suggested if surgery after radiotherapy is indicated, measures to prevent implant loss and development of ORN have to be considered e.g antibiotic prophylaxis and/or pretreatment with HBO. HBO therapy used as an adjunctive treatment for ORN has been associated with improved success rates in the early and intermediate stages. Freiberger et al (2009) in a retrospective study of 65 patients concluded that multi-modality therapy is effective for ORN when less intensive therapies have failed, and McKenzie et al (1993) in a retrospective review found the combination of HBO, other conservative management, and surgery will optimize treatment results in many patients. @ddrcplymouth When is HBO appropriate: HBO may be used to aid wound healing in the presence of ORN or can be administered peri-operatively to help demarcate the non-viable bone or tissue prior to debridement and then used post-operatively to aid wound healing. Evidence: A randomised controlled trial carried out by Bennett et al (2011) found evidence that HBO therapy is more likely to achieve mucosal coverage in the presence of ORN and that it also appears to reduce the chance of ORN following tooth extraction in an irradiated field. HBO should be considered a prophylactic, and/or pre-treatment measure to prevent dental implant loss and development of radionecrosis. Nabil et al (2011) carried out a systematic review of published articles and found, Referral pathway: A referral letter should be sent to our Medical Director, Dr Christine Penny, explaining the reason for referral and highlighting any significant past medical history. Consultant referral is required for treatment funded by the NHS although private medical insurance is also an option. We will be happy to discuss potential referrals if there is any uncertainty about the appropriateness of HBO. Arrangements will be made with the patient for an appointment to assess suitability for treatment. DDRC Healthcare | Hyperbaric Medical Centre | Plymouth | Devon | UK | PL6 8BU References Bennet M et al (2011) Marx RE (1984) HBOT for late radiation tissue injury. Orn of jaws: review and update. Cochrane library. Hyperbaric Oxygen Rev 1984;12(5):78-128 Beumer J, Harrison R, Sanders B, Kurrasch M (1984) Orn: predisposing factors and outcomes of therapy. Head and Neck surgery 1984;6(4):819-27. Maxymiw WG, Wood RE, Liu FF (1991). Postradiation dental extractions without HBOT. Oral Surg Oral Med Oral Pathol 1991;72(3):270-4 Bishop A (2008) Role of oxygen in wound healing. J Wound Care. Vol 17,9:399-402 Curi MM,Dib LL (1997) Orn of the jaws; a retrospective study of the background factors and treatment in 104 cases. J Oral Maxillofac Surg 1997;55(6):540-4 McKenzie MR, Wong FL, Epstein JB, Lepawsky M.(1993) HBO and postradiation osteonecrosis of the mandible. European Journ Cancer B Oral Oncol 1993;29B(3):2017. Nabil S, Samman N (2011) Incidence and prevention of orn after dental extraction in irradiated patients: a systematic review. Int Jou Oral Maxillofac Surg 2011, 40:229-243. Freiberger JJ (2009) Utilty of HBO in treatment of bisphosphonate- related orn of the jaws. Journ of Oral and Maxillofac Surg Jacobson As, Buchbinder D, Hu K, Urken ML (2010) Paradigmn shifts in the management of orn of the mandible. Schoen PJ, Reintsema H, Raghoebar GM, Vissink A, Roodenburg JLN (2003) The use of implant retained mandibular prostheses in the oral rehab of head and neck cancer patients. A review and rationale for treatment planning. Oral Oncology 40;9;862-871. Oral Oncol 2010, 46:795-801 Store G and Boysen M (2000) . Marx RE et al (1987) Mandibular orn: clinical behaviour and diagnostic aspects. Studies in the radiobiology of orn and their clinical significance. Clinical Otolaryngology and Allied Sciences 2000. Wiley online library. Oral Surg Oral Med Oral Pathol 1987;64:379-90 DDRC Healthcare | Hyperbaric Medical Centre | Plymouth | Devon | UK | PL6 8BU
© Copyright 2026 Paperzz